Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Annette Bade is active.

Publication


Featured researches published by Annette Bade.


Optometry and Vision Science | 2009

Validity of the convergence insufficiency symptom survey: a confirmatory study.

Michael W. Rouse; Eric Borsting; G. Lynn Mitchell; Susan A. Cotter; Marjean Kulp; Mitchell Scheiman; Carmen Barnhardt; Annette Bade; Tomohike Yamada; Michael Gallaway; Brandy Scombordi; Mark Boas; Tomohiko Yamada; Ryan Langan; Ruth Shoge; Lily Zhu; Raymond Chu; Susan Parker; Rebecca Bridgeford; Jamie Morris; Javier Villalobos; Jeffrey Cooper; Audra Steiner; Marta Brunelli; Stacy Friedman; Steven Ritter; Lyndon C. Wong; Ida Chung; Ashley Fazarry; Rachel Coulter

Purpose. The objectives of the present study were to evaluate whether investigator bias influenced the Convergence Insufficiency Symptom Survey (CISS) scores of children with normal binocular vision (NBV) in our original validation study, reevaluate the usefulness of the cutoff score of 16, and reexamine the validity of the CISS. Methods. Six clinical sites participating in the Convergence Insufficiency Treatment Trial (CITT) enrolled 46 children 9 to <18 years with NBV. Examiners masked to the child’s binocular vision status administered the CISS. The mean CISS score was compared with that from the children with NBV in the original, unmasked CISS study and also to that of the 221 symptomatic convergence insufficiency (CI) children enrolled in the CITT. Results. The mean (±standard deviation) CISS score for 46 subjects with NBV was 10.4 (±8.1). This was comparable with our prior unmasked NBV study (mean = 8.1 (±6.2); p = 0.11) but was significantly different from that of the CITT CI group (mean = 29.8 ± 9.0; p < 0.001). Eighty-three percent of these NBV subjects scored <16 on the CISS, which is not statistically different from the 87.5% found in the original unmasked study (p = 0.49). Conclusions. Examiner bias did not affect the CISS scores for subjects with NBV in our prior study. The CISS continues to be a valid instrument for quantifying symptoms in 9 to <18-year-old children. These results also confirm the validity of a cut-point of ≥16 in distinguishing children with symptomatic CI from those with NBV.


Optometry and Vision Science | 2013

Relationship between clinical signs and symptoms of convergence insufficiency.

Annette Bade; Mark Boas; Michael Gallaway; G. Lynn Mitchell; Mitchell Scheiman; Marjean Taylor Kulp; Susan A. Cotter; Michael W. Rouse

Purpose The percentage of children who are symptomatic has been shown to increase with the number of signs of convergence insufficiency (CI). Our goal was to investigate whether there is a relationship between the severity of the clinical signs of CI and symptom level reported in children with a three-sign symptomatic CI. Methods The Convergence Insufficiency Treatment Trial enrolled 221 children with symptomatic CI from ages 9 to 17 years. Inclusion criteria included the following three signs of CI: (1) exophoria at near at least 4&Dgr; greater than at distance, (2) insufficient positive fusional vergence (PFV) at near, and (3) a receded near point of convergence (NPC) of 6 cm break or greater. The relationships between the severity of each sign of CI (mild, moderate, and severe) and the level of symptoms as measured by the Convergence Insufficiency Symptom Survey (CISS) at baseline were evaluated. Results Mean CISS scores were not significantly different between mild, moderate, and severe exophoria (p = 0.60), PFV blur (p = 0.99), Sheard’s criterion (p = 0.89), or NPC break (p = 0.84). There was also no difference between the frequency of subjects scoring at mild, moderate, or severe levels on the CISS and the severity of each sign of CI. Correlations between individual clinical signs and the CISS score were very low and not statistically significant. Conclusions Among symptomatic children with a CISS score of 16 or higher and three clinical signs of CI, there is no further association between the severity of the clinical signs and their level of symptoms.


Optometry and Vision Science | 2015

Eye examination testability in children with autism and in typical peers.

Rachel Coulter; Annette Bade; Yin Tea; Gregory Fecho; Deborah Amster; Erin Jenewein; Jacqueline Rodena; Kara Kelley Lyons; G. Lynn Mitchell; Nicole Quint; Sandra Dunbar; Michele Ricamato; Jennie Trocchio; Bonnie Kabat; Chantel Garcia; Irina Radik

Purpose To compare testability of vision and eye tests in an examination protocol of 9- to 17-year-old patients with autism spectrum disorder (ASD) to typically developing (TD) peers. Methods In a prospective pilot study, 61 children and adolescents (34 with ASD and 27 who were TD) aged 9 to 17 years completed an eye examination protocol including tests of visual acuity, refraction, convergence (eye teaming), stereoacuity (depth perception), ocular motility, and ocular health. Patients who required new refractive correction were retested after wearing their updated spectacle prescription for 1 month. The specialized protocol incorporated visual, sensory, and communication supports. A psychologist determined group status/eligibility using DSM-IV-TR (Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision) criteria by review of previous evaluations and parent responses on the Social Communication Questionnaire. Before the examination, parents provided information regarding patients’ sex, race, ethnicity, and, for ASD patients, verbal communication level (nonverbal, uses short words, verbal). Parents indicated whether the patient wore a refractive correction, whether the patient had ever had an eye examination, and the age at the last examination. Chi-square tests compared testability results for TD and ASD groups. Results Typically developing and ASD groups did not differ by age (p = 0.54), sex (p = 0.53), or ethnicity (p = 0.22). Testability was high on most tests (TD, 100%; ASD, 88 to 100%), except for intraocular pressure (IOP), which was reduced for both the ASD (71%) and the TD (89%) patients. Among ASD patients, IOP testability varied greatly with verbal communication level (p < 0.001). Although IOP measurements were completed on all verbal patients, only 37.5% of nonverbal and 44.4% of ASD patients who used short words were successful. Conclusions Patients with ASD can complete most vision and eye tests within an examination protocol. Testability of IOPs is reduced, particularly for nonverbal patients and patients who use short words to communicate.


conference on computers and accessibility | 2004

Strategic design for users with diabetic retinopathy: factors influencing performance in a menu-selection task

Paula J. Edwards; Leon Barnard; V. Kathlene Emery; Ji Soo Yi; Kevin P. Moloney; Thitima Kongnakorn; Julie A. Jacko; François Sainfort; Pamela Oliver; Joseph Pizzimenti; Annette Bade; Greg Fecho; Josephine Shallo-Hoffmann

This paper examines factors that affect performance of a basic menu selection task by users who are visually healthy and users with Diabetic Retinopathy (DR) in order to inform better interface design. Interface characteristics such as multimodal feedback, Windows® accessibility settings, and menu item location were investigated. Analyses of Variance (ANOVA) were employed to examine the effects of interface features on task performance. Linear regression was used to further examine and model various contextual factors that influenced task performance. Results indicated that Windows® accessibility settings significantly improved performance of participants with more progressed DR. Additionally, other factors, including age, computer experience, visual acuity, and menu location were significant predictors of the time required for subjects to complete the task.


The Internet Journal of Allied Health Sciences & Practice | 2007

Interdisciplinary Management of Diabetic Eye Disease: A Global Approach to Care

Annette Bade; Joseph Pizzimenti


Archive | 2004

Risk factors for diabetic retinopathy

Annette Bade; Joseph Pizzimenti; Pamela Oliver; Patrick C. Hardigan


Investigative Ophthalmology & Visual Science | 2016

Reliability of Quick Contrast Sensitivity Function Testing in Adults without Ocular Disease and Patients with Retinitis Pigmentosa

Manonmani Murugappan; Jeslyn Vayalil; Annette Bade; Ava K Bittner


Optometry - Journal of The American Optometric Association | 2007

Poster 77: The Inconsistency Spectrum of Wavefront Analysis

Pamela Oliver; Annette Bade; Perla Najman; Patrick C. Hardigan; Armando Barreto


Optometry - Journal of The American Optometric Association | 2005

Poster 21 - When One Is Better Than Two: Binocular Contrast Sensitivity in Subjects With ARMD

Jacqueline Burkhardt; Jacqueline Pierre; Joseph Pizzimenti; Diane Calderon; Annette Bade; Pamela Oliver; Panes Harris-Roberts; Takeia Locke; V Leonard; Julie A. Jacko


Archive | 2004

Cigarette smoking and catarct in patients with diabetes

Annette Bade; Joseph Pizzimenti; Pamela Oliver; Patrick C. Hardigan

Collaboration


Dive into the Annette Bade's collaboration.

Top Co-Authors

Avatar

Joseph Pizzimenti

Nova Southeastern University

View shared research outputs
Top Co-Authors

Avatar

Pamela Oliver

Nova Southeastern University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Julie A. Jacko

Georgia Institute of Technology

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Michael W. Rouse

Marshall B. Ketchum University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Rachel Coulter

Nova Southeastern University

View shared research outputs
Top Co-Authors

Avatar

Susan A. Cotter

University of Southern California

View shared research outputs
Researchain Logo
Decentralizing Knowledge